The use of aerosolized - Adrenergic agonist therapy after lung transplantation in pediatric age
<p>It is my opinion the use of aeresolized -adrenergic agonist such as salbutamol may be helpfull not only to reduced the early mortality but also the chronic allograft dysfunction after lung transplantation in children The reduction of pulmonary edema could be prevent the induction of Ob...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Archives of Pulmonology and Respiratory Care - Peertechz Publications,
2020-06-29.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_aprc_000055 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Giorgia Grutter |e author |
| 700 | 1 | 0 | |a Zaccaria Ricci |e author |
| 245 | 0 | 0 | |a The use of aerosolized - Adrenergic agonist therapy after lung transplantation in pediatric age |
| 260 | |b Archives of Pulmonology and Respiratory Care - Peertechz Publications, |c 2020-06-29. | ||
| 520 | |a <p>It is my opinion the use of aeresolized -adrenergic agonist such as salbutamol may be helpfull not only to reduced the early mortality but also the chronic allograft dysfunction after lung transplantation in children The reduction of pulmonary edema could be prevent the induction of Obstructive Bronchiolites Syndrome (less pneumonia and viral infections etc) such as the primary graft dysfunction.As we know by international literature Lung transplantation continues to suffer from less-than-ideal long-term outcomes, even in pediatric patients.</p> | ||
| 540 | |a Copyright © Giorgia Grutter et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Opinion |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/aprc.000055 |z Connect to this object online. |